IOL Chemicals & Pharmaceuticals Ltd.

NSE: IOLCP  SECTOR: Pharmaceuticals & Drugs

522.6
+31.65 (6.45%)

Price Summary

Today's High

₹ 529.55

Today's Low

₹ 483.2

52 Week High

₹ 503.25

52 Week Low

₹ 147.35

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.

Company Essentials

Market Cap

3067.94953452 Cr.

Enterprise Value

3322.34953452 Cr.

No. of Shares

5.8705502 Cr.

P/E

8.49

P/B

3.61

Face Value

₹ 10

Div. Yield

0.57%

Book Value (TTM)

₹  144.8921

CASH

29.6 Cr.

DEBT

284 Cr.

Promoter Holding

41.89%

EPS (TTM)

₹  61.5428

Sales Growth

71.3953015356453%

ROE

69.5399259650978 %

ROCE

55.5273790079945 %

Profit Growth

14.0447271454255 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1w1m3m6m1Yr3Yr5Yr

* Prices are based on daily market changes.

Valuation Chart 1w1m3m6m1Yr3Yr5Yr

* The chart is based on the standalone earnings of the company.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Sales Growth (in Cr.)

1 Year71.4%
3 Year42.66%
5 Year24.5%

Profit Growth (in Cr.)

1 Year754.51%
3 Year99.28%
5 Year135.05%

ROE%

1 Year69.54%
3 Year28.58%
5 Year6.18%

ROCE %

1 Year55.53%
3 Year27.37%
5 Year16.6%

Debt/Equity

0.610726420369016

Price to Cash Flow

11.23

Interest Cover Ratio

7.53733955659277

CFO/PAT (5 Yr. Avg.)

4.71683970089424

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2019 41.89 0
Sep 2019 41.89 0
Jun 2019 41.89 0
Mar 2019 41.89 0
Dec 2018 41.19 0
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 99.2780860358487% for the Past 3 years.
  • The company has shown a good revenue growth of 42.6638082159033% for the Past 3 years.
  • The company has significantly decreased its debt by 137.88 Cr.
  • Company has been maintaining healthy ROE of 28.578781880767% over the past 3 years.
  • Company has been maintaining healthy ROCE of 27.3740346713218% over the past 3 years.
  • Company’s PEG ratio is 0.0114089288333537.
  • The company has an efficient Cash Conversion Cycle of 42.5718095705477 days.
  • The company has a good cash flow management; CFO/PAT stands at 4.71683970089424.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 4.97141855350647.

 Limitations

 Looks like the company does not have any serious limitations.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020
Net Sales 422.29 492.8 448.96 511.25 441.46
Total Expenditure 265.15 348.19 316.04 351.75 304.61
Operating Profit 157.14 144.61 132.92 159.5 136.85
Other Income 2.2 3.32 3.39 3.96 5.35
Interest 8.83 8.32 6.09 3.76 2.76
Depreciation 7.99 8.59 8.84 8.94 9.36
Exceptional Items 0 0 0 0 0
Profit Before Tax 142.52 131.02 121.38 150.76 130.08
Tax 40.87 45.7 33.68 52.75 39.82
Profit After Tax 101.65 85.32 87.7 98.01 90.26
Adjusted EPS (Rs) 1.79 1.5 1.54 1.72 1.59

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
Net Sales 384.73 580.42 710.65 983.3 1685.33
Total Expenditure 373.46 529.04 608.45 863.77 1275.68
Operating Profit 11.26 51.37 102.2 119.53 409.65
Other Income 1.32 1.23 1.25 6.33 10.37
Interest 59.11 61.47 67.68 64.35 51.42
Depreciation 28.91 29.69 29.84 30.21 32.45
Exceptional Items 0 0 0 0 0
Profit Before Tax -75.44 -38.55 5.93 31.3 336.15
Tax -8.79 1.48 1.26 3.6 99.45
Net Profit -66.65 -40.03 4.67 27.7 236.7
Adjusted EPS (Rs.) -13.99 -7.12 0.83 4.93 41.61

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
Equity and Liabilities
Share Capital 47.66 56.21 56.21 56.21 56.89
Total Reserves 159.54 128.92 132.49 159.53 417.45
Borrowings 277.1 301.88 284.98 258.12 189.88
Other N/C liabilities 8.77 2.55 9.25 22.17 20.77
Current liabilities 208.54 282.92 327.67 350.97 324.38
Total Liabilities 701.61 772.49 810.6 847 1009.37
Assets
Net Block 402.82 399.5 373.88 405.64 411.72
Capital WIP 4.21 4.31 21.26 6.95 27.02
Investments 0.04 0.04 0.05 0 0
Loans & Advances 10.75 9.01 0.38 1.26 7.78
Other N/C Assets 0.3 2.77 0.37 2.17 7.3
Current Assets 283.49 356.86 414.66 430.98 555.55
Total Assets 701.61 772.49 810.6 847 1009.37
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
Profit Before Tax -75.44 -38.55 5.93 31.3 336.15
Adjustment 81.73 83.92 95.92 91.64 82.35
Working Capital Changes -52.83 -27.67 -17.45 3.14 -77.64
Tax Paid -0.42 0 -1.06 -6.36 -67.69
Operating Cash Flow -46.96 17.7 83.34 119.72 273.17
Investing Cash Flow -4.79 -27.37 -22.78 -50.38 -63.04
Financing Cash Flow 49.69 9.27 -59.78 -70.36 -197.46
Net Cash Flow -2.07 -0.4 0.78 -1.02 12.67

Corporate Actions

Ratings & Research Reports

Company Presentations

Currently we do not have any Presentation and Concall related to this company.
Report us

Company News

IOL Chem & Pharma Stock Price Analysis and Quick Research Report. Is IOL Chem & Pharma an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into IOL Chem & Pharma and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 273.17 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. IOL Chem & Pharma has a Debt to Equity ratio of 0.610726420369016 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In IOL Chem & Pharma , the EPS growth was 744.298738524469 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, IOL Chem & Pharma has OPM of 24.3068123156889 % which is a good sign for profitability.
     
  • ROE: IOL Chem & Pharma have a healthy ROE of 69.5399259650978 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about IOL Chem & Pharma

X